HNRPF_HUMAN - dbPTM
HNRPF_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HNRPF_HUMAN
UniProt AC P52597
Protein Name Heterogeneous nuclear ribonucleoprotein F
Gene Name HNRNPF
Organism Homo sapiens (Human).
Sequence Length 415
Subcellular Localization Nucleus, nucleoplasm.
Protein Description Component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Plays a role in the regulation of alternative splicing events. Binds G-rich sequences in pre-mRNAs and keeps target RNA in an unfolded state..
Protein Sequence MMLGPEGGEGFVVKLRGLPWSCSVEDVQNFLSDCTIHDGAAGVHFIYTREGRQSGEAFVELGSEDDVKMALKKDRESMGHRYIEVFKSHRTEMDWVLKHSGPNSADSANDGFVRLRGLPFGCTKEEIVQFFSGLEIVPNGITLPVDPEGKITGEAFVQFASQELAEKALGKHKERIGHRYIEVFKSSQEEVRSYSDPPLKFMSVQRPGPYDRPGTARRYIGIVKQAGLERMRPGAYSTGYGGYEEYSGLSDGYGFTTDLFGRDLSYCLSGMYDHRYGDSEFTVQSTTGHCVHMRGLPYKATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEEAVAAMSKDRANMQHRYIELFLNSTTGASNGAYSSQVMQGMGVSAAQATYSGLESQSVSGCYGAGYSGQNSMGGYD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MMLGPEGG
-------CCCCCCCC
4.5222814378
2Acetylation------MMLGPEGGE
------CCCCCCCCC
6.2722223895
2Sulfoxidation------MMLGPEGGE
------CCCCCCCCC
6.2728183972
14UbiquitinationGGEGFVVKLRGLPWS
CCCCEEEEECCCCCC
27.4521906983
21PhosphorylationKLRGLPWSCSVEDVQ
EECCCCCCCCHHHHH
8.4528464451
23PhosphorylationRGLPWSCSVEDVQNF
CCCCCCCCHHHHHHH
24.0328464451
32PhosphorylationEDVQNFLSDCTIHDG
HHHHHHHHCCEEECC
26.8828464451
35PhosphorylationQNFLSDCTIHDGAAG
HHHHHCCEEECCCCE
26.7428464451
54PhosphorylationYTREGRQSGEAFVEL
EECCCCCCCCEEEEE
36.9229214152
63PhosphorylationEAFVELGSEDDVKMA
CEEEEECCHHHHHHH
50.9420873877
68SumoylationLGSEDDVKMALKKDR
ECCHHHHHHHHHHHH
26.00-
68UbiquitinationLGSEDDVKMALKKDR
ECCHHHHHHHHHHHH
26.00-
72SumoylationDDVKMALKKDRESMG
HHHHHHHHHHHHHHC
42.99-
72SumoylationDDVKMALKKDRESMG
HHHHHHHHHHHHHHC
42.9915161980
77PhosphorylationALKKDRESMGHRYIE
HHHHHHHHHCHHHHH
30.8429496963
82PhosphorylationRESMGHRYIEVFKSH
HHHHCHHHHHHHHHC
8.8523663014
87MethylationHRYIEVFKSHRTEMD
HHHHHHHHHCHHHCE
50.9919608861
87AcetylationHRYIEVFKSHRTEMD
HHHHHHHHHCHHHCE
50.9925825284
87UbiquitinationHRYIEVFKSHRTEMD
HHHHHHHHHCHHHCE
50.9921890473
87MalonylationHRYIEVFKSHRTEMD
HHHHHHHHHCHHHCE
50.9926320211
87SumoylationHRYIEVFKSHRTEMD
HHHHHHHHHCHHHCE
50.9928112733
90MethylationIEVFKSHRTEMDWVL
HHHHHHCHHHCEEHH
39.20115479107
93SulfoxidationFKSHRTEMDWVLKHS
HHHCHHHCEEHHHCC
4.9328183972
98AcetylationTEMDWVLKHSGPNSA
HHCEEHHHCCCCCCC
26.5521466224
98UbiquitinationTEMDWVLKHSGPNSA
HHCEEHHHCCCCCCC
26.5521890473
98MalonylationTEMDWVLKHSGPNSA
HHCEEHHHCCCCCCC
26.5526320211
100PhosphorylationMDWVLKHSGPNSADS
CEEHHHCCCCCCCCC
55.1230266825
104PhosphorylationLKHSGPNSADSANDG
HHCCCCCCCCCCCCC
36.2629255136
107PhosphorylationSGPNSADSANDGFVR
CCCCCCCCCCCCCEE
28.7830266825
114MethylationSANDGFVRLRGLPFG
CCCCCCEEECCCCCC
19.19115479091
142PhosphorylationEIVPNGITLPVDPEG
EECCCCEEEECCCCC
26.8018452278
150SumoylationLPVDPEGKITGEAFV
EECCCCCCCCHHHHH
35.12-
152PhosphorylationVDPEGKITGEAFVQF
CCCCCCCCHHHHHHH
32.2427251275
161PhosphorylationEAFVQFASQELAEKA
HHHHHHHCHHHHHHH
26.0217525332
167UbiquitinationASQELAEKALGKHKE
HCHHHHHHHHHHHHH
43.2221906983
167SumoylationASQELAEKALGKHKE
HCHHHHHHHHHHHHH
43.2228112733
167AcetylationASQELAEKALGKHKE
HCHHHHHHHHHHHHH
43.2226051181
171UbiquitinationLAEKALGKHKERIGH
HHHHHHHHHHHHHCH
52.97-
180PhosphorylationKERIGHRYIEVFKSS
HHHHCHHHHHHHHCC
8.8523403867
185SumoylationHRYIEVFKSSQEEVR
HHHHHHHHCCHHHHH
55.14-
185UbiquitinationHRYIEVFKSSQEEVR
HHHHHHHHCCHHHHH
55.1421890473
185SumoylationHRYIEVFKSSQEEVR
HHHHHHHHCCHHHHH
55.1428112733
185AcetylationHRYIEVFKSSQEEVR
HHHHHHHHCCHHHHH
55.1426051181
186PhosphorylationRYIEVFKSSQEEVRS
HHHHHHHCCHHHHHH
26.2830266825
187PhosphorylationYIEVFKSSQEEVRSY
HHHHHHCCHHHHHHC
42.0530266825
193PhosphorylationSSQEEVRSYSDPPLK
CCHHHHHHCCCCCCE
33.8828152594
194PhosphorylationSQEEVRSYSDPPLKF
CHHHHHHCCCCCCEE
13.4128152594
195PhosphorylationQEEVRSYSDPPLKFM
HHHHHHCCCCCCEEE
44.9121815630
200AcetylationSYSDPPLKFMSVQRP
HCCCCCCEEEEECCC
44.8127452117
200SumoylationSYSDPPLKFMSVQRP
HCCCCCCEEEEECCC
44.81-
200UbiquitinationSYSDPPLKFMSVQRP
HCCCCCCEEEEECCC
44.8121906983
200SumoylationSYSDPPLKFMSVQRP
HCCCCCCEEEEECCC
44.8128112733
202SulfoxidationSDPPLKFMSVQRPGP
CCCCCEEEEECCCCC
3.5228183972
203PhosphorylationDPPLKFMSVQRPGPY
CCCCEEEEECCCCCC
20.4528796482
210PhosphorylationSVQRPGPYDRPGTAR
EECCCCCCCCCCCHH
30.4225101063
212DimethylationQRPGPYDRPGTARRY
CCCCCCCCCCCHHHH
26.21-
212MethylationQRPGPYDRPGTARRY
CCCCCCCCCCCHHHH
26.2154556609
215PhosphorylationGPYDRPGTARRYIGI
CCCCCCCCHHHHHHH
21.4823401153
217MethylationYDRPGTARRYIGIVK
CCCCCCHHHHHHHHH
31.6054556617
218MethylationDRPGTARRYIGIVKQ
CCCCCHHHHHHHHHH
25.5980702355
219PhosphorylationRPGTARRYIGIVKQA
CCCCHHHHHHHHHHH
9.6528152594
224MethylationRRYIGIVKQAGLERM
HHHHHHHHHHCHHHC
32.2922641049
224AcetylationRRYIGIVKQAGLERM
HHHHHHHHHHCHHHC
32.2919608861
224SumoylationRRYIGIVKQAGLERM
HHHHHHHHHHCHHHC
32.29-
224UbiquitinationRRYIGIVKQAGLERM
HHHHHHHHHHCHHHC
32.2921906983
224SumoylationRRYIGIVKQAGLERM
HHHHHHHHHHCHHHC
32.2928112733
231SulfoxidationKQAGLERMRPGAYST
HHHCHHHCCCCCCCC
4.4128183972
232MethylationQAGLERMRPGAYSTG
HHCHHHCCCCCCCCC
32.49115479099
236PhosphorylationERMRPGAYSTGYGGY
HHCCCCCCCCCCCCC
16.8122817900
237PhosphorylationRMRPGAYSTGYGGYE
HCCCCCCCCCCCCCC
18.1528348404
238PhosphorylationMRPGAYSTGYGGYEE
CCCCCCCCCCCCCCC
23.0321082442
240PhosphorylationPGAYSTGYGGYEEYS
CCCCCCCCCCCCCCC
13.8922817900
243PhosphorylationYSTGYGGYEEYSGLS
CCCCCCCCCCCCCCC
10.9622817900
246PhosphorylationGYGGYEEYSGLSDGY
CCCCCCCCCCCCCCC
8.9727259358
247PhosphorylationYGGYEEYSGLSDGYG
CCCCCCCCCCCCCCC
36.22-
250PhosphorylationYEEYSGLSDGYGFTT
CCCCCCCCCCCCCCH
32.3024275569
253PhosphorylationYSGLSDGYGFTTDLF
CCCCCCCCCCCHHHC
17.6620090780
265PhosphorylationDLFGRDLSYCLSGMY
HHCCCCHHHHHHCCC
20.3525159151
265O-linked_GlycosylationDLFGRDLSYCLSGMY
HHCCCCHHHHHHCCC
20.3523301498
266PhosphorylationLFGRDLSYCLSGMYD
HCCCCHHHHHHCCCC
12.5227134283
267GlutathionylationFGRDLSYCLSGMYDH
CCCCHHHHHHCCCCC
1.8822555962
269PhosphorylationRDLSYCLSGMYDHRY
CCHHHHHHCCCCCCC
20.2530576142
272PhosphorylationSYCLSGMYDHRYGDS
HHHHHCCCCCCCCCC
16.4829978859
276PhosphorylationSGMYDHRYGDSEFTV
HCCCCCCCCCCEEEE
23.1223312004
279PhosphorylationYDHRYGDSEFTVQST
CCCCCCCCEEEEEEC
30.1928442448
282PhosphorylationRYGDSEFTVQSTTGH
CCCCCEEEEEECCCC
17.3728442448
285PhosphorylationDSEFTVQSTTGHCVH
CCEEEEEECCCCEEE
24.4923312004
286PhosphorylationSEFTVQSTTGHCVHM
CEEEEEECCCCEEEE
21.5023312004
287PhosphorylationEFTVQSTTGHCVHMR
EEEEEECCCCEEEEC
30.1223312004
290GlutathionylationVQSTTGHCVHMRGLP
EEECCCCEEEECCCC
2.0822555962
299UbiquitinationHMRGLPYKATENDIY
EECCCCCCCCCCCCH
47.0621906983
301PhosphorylationRGLPYKATENDIYNF
CCCCCCCCCCCCHHC
31.0427987026
306PhosphorylationKATENDIYNFFSPLN
CCCCCCCHHCCCCCC
14.5829255136
310PhosphorylationNDIYNFFSPLNPVRV
CCCHHCCCCCCCEEE
25.0829255136
328PhosphorylationIGPDGRVTGEADVEF
ECCCCCCCEECCEEE
28.13-
337PhosphorylationEADVEFATHEEAVAA
ECCEEEHHHHHHHHH
34.8321601212
346PhosphorylationEEAVAAMSKDRANMQ
HHHHHHHCHHCHHHH
27.0321601212
347UbiquitinationEAVAAMSKDRANMQH
HHHHHHCHHCHHHHH
37.84-
401PhosphorylationSQSVSGCYGAGYSGQ
CCCCCCCCCCCCCCC
17.3422817900
406PhosphorylationGCYGAGYSGQNSMGG
CCCCCCCCCCCCCCC
32.7426074081
410PhosphorylationAGYSGQNSMGGYD--
CCCCCCCCCCCCC--
15.7726074081
414PhosphorylationGQNSMGGYD------
CCCCCCCCC------
16.8626074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HNRPF_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HNRPF_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HNRPF_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RBMX_HUMANRBMXphysical
22939629
HNRPK_HUMANHNRNPKphysical
22939629
HNRPR_HUMANHNRNPRphysical
22939629
SRSF1_HUMANSRSF1physical
22939629
HNRPM_HUMANHNRNPMphysical
22939629
SRSF7_HUMANSRSF7physical
22939629
U2AF2_HUMANU2AF2physical
22939629
ROA0_HUMANHNRNPA0physical
22939629
RBP2_HUMANRANBP2physical
22939629
MIRO2_HUMANRHOT2physical
22939629
MOGS_HUMANMOGSphysical
22939629
NOL11_HUMANNOL11physical
22939629
PLP2_HUMANPLP2physical
22939629
PEX3_HUMANPEX3physical
22939629
RAB21_HUMANRAB21physical
22939629
NDUF4_HUMANNDUFAF4physical
22939629
RAB14_HUMANRAB14physical
22939629
RADI_HUMANRDXphysical
22939629
RU1C_HUMANSNRPCphysical
22365833
SF3B4_HUMANSF3B4physical
22365833
SF01_HUMANSF1physical
22365833
ROA0_HUMANHNRNPA0physical
22365833
HNRL1_HUMANHNRNPUL1physical
22365833
RBM4_HUMANRBM4physical
22365833
HNRPD_HUMANHNRNPDphysical
22365833
HNRH3_HUMANHNRNPH3physical
22365833
TOE1_HUMANTOE1physical
22365833
RFOX2_HUMANRBFOX2physical
22365833
TGM2_HUMANTGM2physical
21988832
ARP3_HUMANACTR3physical
22863883
ZPR1_HUMANZPR1physical
22863883
HNRPM_HUMANHNRNPMphysical
25416956
DZIP3_HUMANDZIP3physical
25416956
TFG_HUMANTFGphysical
25416956
HNRL1_HUMANHNRNPUL1physical
25416956
IKZF3_HUMANIKZF3physical
25416956
RFOX2_HUMANRBFOX2physical
25416956
4ET_HUMANEIF4ENIF1physical
25416956
CCD33_HUMANCCDC33physical
25416956
CA094_HUMANC1orf94physical
25416956
HSFY1_HUMANHSFY1physical
25416956
BASP1_HUMANBASP1physical
26344197
PUF60_HUMANPUF60physical
26344197
CCD33_HUMANCCDC33physical
21516116
CARF_HUMANCDKN2AIPphysical
28514442
ZCHC8_HUMANZCCHC8physical
28514442
ACOX1_HUMANACOX1physical
28514442
SPT5H_HUMANSUPT5Hphysical
28514442
DPP9_HUMANDPP9physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HNRPF_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, AND MASSSPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-87 AND LYS-224, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 AND SER-310, ANDMASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187 AND SER-310, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-161, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-246, AND MASSSPECTROMETRY.
Sumoylation
ReferencePubMed
"Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc fingerproteins, and nuclear pore complex proteins: a proteomic analysis.";
Li T., Evdokimov E., Shen R.F., Chao C.C., Tekle E., Wang T.,Stadtman E.R., Yang D.C., Chock P.B.;
Proc. Natl. Acad. Sci. U.S.A. 101:8551-8556(2004).
Cited for: SUMOYLATION AT LYS-72.

TOP